New Key Statistics Module, Z-Score and F-Score
SZSE:002550 Key Ratios
Market Cap ¥ M | 6,731.75 |
Enterprise Value ¥ M | 6,200.86 |
P/E(ttm) | 27.20 |
PE Ratio without NRI | 28.38 |
Forward PE Ratio | 22.87 |
Price/Book | 2.86 |
Price/Sales | 4.17 |
Price/Free Cash Flow | 10.89 |
Price/Owner Earnings | 39.47 |
Payout Ratio % | 0.65 |
Revenue (TTM) ¥ M | 1,613.00 |
EPS (TTM) ¥ | 0.19 |
Beneish M-Score | -3.37 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 6.30 |
EV-to-EBIT | 22.37 |
EV-to-EBITDA | 22.37 |
PEG | -- |
Shares Outstanding M | 1,279.80 |
Net Margin (%) | 15.23 |
Operating Margin % | 15.58 |
Pre-tax Margin (%) | 17.00 |
Quick Ratio | 5.85 |
Current Ratio | 8.43 |
ROA % (ttm) | 8.91 |
ROE % (ttm) | 10.17 |
ROIC % (ttm) | 10.74 |
Dividend Yield % | 2.25 |
Altman Z-Score | 16.90 |
SZSE:002550 Number of Guru Trades
SZSE:002550 Volume of Guru Trades
Gurus Latest Trades with SZSE:002550
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002550 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Changzhou Qianhong Biopharma Co Ltd Insider Transactions
No Available Data